Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial. (2020)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13054-020-03243-4
PubMed Identifier: 33172504
Publication URI: http://europepmc.org/abstract/MED/33172504
Type: Journal Article/Review
Volume: 24
Parent Publication: Critical care (London, England)
Issue: 1
ISSN: 1364-8535